IL6 and COVID-19: That study revealed an enriched antigen-specific Th1-type cytokine profile in recovered COVID-19 patients, whereas individuals with Long-COVID exhibited significantly elevated levels of inflammatory cytokines IL-1β and IL-6 compared to the unexposed group, two months after acute infection.